Anhui Wanbang Pharmaceutical TechnologyLtd Balance Sheet Health
Financial Health criteria checks 6/6
Anhui Wanbang Pharmaceutical TechnologyLtd has a total shareholder equity of CN¥1.5B and total debt of CN¥0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are CN¥1.6B and CN¥75.1M respectively. Anhui Wanbang Pharmaceutical TechnologyLtd's EBIT is CN¥86.0M making its interest coverage ratio -12.9. It has cash and short-term investments of CN¥1.1B.
Key information
0%
Debt to equity ratio
CN¥0
Debt
| Interest coverage ratio | -12.9x |
| Cash | CN¥1.15b |
| Equity | CN¥1.49b |
| Total liabilities | CN¥75.10m |
| Total assets | CN¥1.57b |
Recent financial health updates
No updates
Financial Position Analysis
Short Term Liabilities: 301520's short term assets (CN¥1.4B) exceed its short term liabilities (CN¥57.8M).
Long Term Liabilities: 301520's short term assets (CN¥1.4B) exceed its long term liabilities (CN¥17.3M).
Debt to Equity History and Analysis
Debt Level: 301520 is debt free.
Reducing Debt: 301520 has no debt compared to 5 years ago when its debt to equity ratio was 15%.
Debt Coverage: 301520 has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: 301520 has no debt, therefore coverage of interest payments is not a concern.